Acute leukemias discussion: what does genomics and epigenomics tell us about patient management?
Ari Melnick et al.
The current status of CLL treatment
Bispecific agents: the future of AML and MDS treatment?
Studying the evolution of acute myeloid leukemia (AML) relapse
Cytokine release syndrome: a limiting factor for AML treatment